This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
| Yesterday’s UK 100 Leaders | Price (p) | % Chg |
| JUST EAT TAKEAWAY | 7,855.0 | 6.8% |
| POLYMETAL INTERNATIONAL PLC | 1,499.5 | 3.6% |
| AUTO TRADER GROUP PLC | 590.4 | 3.5% |
| JD SPORTS FASHION PLC | 940.8 | 3.0% |
| WEIR GROUP PLC/THE | 1,894.0 | 2.7% |
| Yesterday’s UK 100 Laggards | Price (p) | % Chg |
| UNITED UTILITIES GROUP PLC | 946.8 | -2.4% |
| SEVERN TRENT PLC | 2393.0 | -1.6% |
| LLOYDS BANKING GROUP PLC | 43.8 | -1.4% |
| SSE PLC | 1511.0 | -1.4% |
| INTL CONSOLIDATED AIRLINE-DI | 203.4 | -1.4% |
| Major World Indices | Price | % Chg | 1 YEAR |
| UK 100 INDEX | 6,890 | 0.0% | 19.0% |
| DOW JONES INDUS. AVG | 33,677 | -0.2% | 40.6% |
| DAX INDEX | 15,234 | 0.1% | 42.4% |
| NIKKEI 225 | 29,621 | -0.4% | 50.8% |
| S&P/ASX 200 INDEX | 7,023 | 0.7% | 28.0% |
| Commodities | Units | Price | % Chg |
| WTI Crude Oil (Nymex) | USD/bbl. | 60.96 | 1.30% |
| Brent Crude (ICE) | USD/bbl. | 64.53 | 1.35% |
| Gold Spot | USD/t oz. | 1,748 | 0.1% |
| Copper (Comex) | USd/lb. | 404 | 0.2% |
UK 100 is called to open +10 points this morning at 6900. A modestly higher open is expected today on the back of a pull back during yesterday's session stateside, pulled lower by concerns over Johnson & Johnson’s Covid vaccine after its one-shot jab was suspended in the US over concerns about rare blood clots similar to those experienced by a small number of AstraZeneca vaccine receivers. In spite of this tech stocks once again striking fresh highs. Investors will take some home from a sharp fall in US bond yields, which is a barometer for interest rates. The mixed session in the US saw the Dow Jones closing down 0.2% at 33,677,. A strong performance for tech stocks saw the Nasdaq rise by 1.05% to 13,996 and the S&P 500 climbing 0.33% to a record high of 4,141. It was equally mixed this morning in Asia, with Japan’s Nikkei 225 closing down 0.3% while Hong Kong’s Hang Seng was up 1.42%.
AstraZeneca's lung cancer treatment drug Tagrisso has been approved for use in China.
British Land opens 79% of its stores as this week following the easing of restrictions.
EasyJet H1 results beat market expectations as they posted a pretax loss of between £690-730m. Their Q2 cashburn is better than previously guided as their passenger numbers were down 89% to 4.1m and their revenue fell 90% to £235m. They expect to fly up to 20% of 2019 capacity levels in Q3.
Foxtons says they have started the year well with Q1 revenue up 24% YoY to £28.5m.
Tesco beat guidance by reporting a total retail operating profit before exceptionals of £1.99bn after seeing "exceptionally strong" sales during the COVID-19 pandemic. They state that the majority of additional costs due to the pandemic won't be repeated in the new FY. They held their annual dividend at 9.15p per share.
Goldman Sachs Upgrades Glencore to Buy from Neutral (8 Buys / 7 Holds / 0 Sells)
HSBC Upgrades Tullow Oil to Hold from Reduce (2 Buys / 6 Holds / 6 Sells)
JP Morgan Downgrades Restaurant Group to Neutral from Overweight (9 Buys / 3 Holds / 0 Sells)
None
Hays
Oxford Biomedica
Travis Perkins
EU Industrial Production s.a.
Fed's Beige Book
Fed's Williams speech
UK 100:
Barratt Developments
Lloyds Banking Group
St. James's Place
Standard Life Aberdeen
Legal & General Group
UK 250:
Jupiter Fund Management
Vesuvius
F&C Investment Trust
Ibstock
Unite Group
For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.